CO

Clodagh O'Shea

SS Salk Institute For Biological Studies: 14 patents #18 of 521Top 4%
📍 San Diego, CA: #3,133 of 23,606 inventorsTop 15%
🗺 California: #43,449 of 386,348 inventorsTop 15%
Overall (All Time): #333,139 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12365878 Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4 Michael Lyman, William N. Partlo, Shigeki Miyake-Stoner 2025-07-22
12281324 Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics William N. Partlo, Colin Powers 2025-04-22
11813337 Tumor-targeting synthetic adenoviruses and uses thereof Colin Powers, Lei Zhang 2023-11-14
11730781 Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration Colin Powers, Lei Zhang 2023-08-22
11401529 Exogenous gene expression in recombinant adenovirus for minimal impact on viral kinetics William N. Partlo, Colin Powers 2022-08-02
11130968 High throughput assay for measuring adenovirus replication kinetics William N. Partlo, Colin Powers 2021-09-28
11077156 Oncolytic adenovirus compositions Shigeki Miyake-Stoner 2021-08-03
10821141 HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancers Jason DeHart 2020-11-03
10738325 Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics William N. Partlo, Colin Powers 2020-08-11
10577589 Adenoviral assembly method Colin Powers 2020-03-03
9913866 Selective cell targeting using adenovirus and chemical dimers Shigeki Miyake-Stoner, Colin Powers 2018-03-13
9885090 Adenoviral tumor diagnostics Colin Powers 2018-02-06
9217160 Adenoviral assembly method Colin Powers 2015-12-22
9187733 Anti-cancer adenoviruses Colin Powers 2015-11-17